J Viral Hepat. 2026 Jan;33(1):e70109. doi: 10.1111/jvh.70109.
ABSTRACT
This was a nonblinded randomised controlled trial comparing pharmacist-led hepatitis C virus (HCV) treatment in the community, to tertiary care hepatology. Of 34 antibody-positive individuals, 28 completed a rapid HCV RNA test in the pharmacy. The study was terminated after randomising 11 participants over 15 months (recruitment continued until ~27 months), as a result of feasibility concerns of pharmacist-led care, and here we highlight important lessons learned to consider for future efforts.
PMID:41307439 | DOI:10.1111/jvh.70109
